OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.680
+0.020 (1.20%)
At close: Apr 2, 2026, 4:00 PM EDT
1.660
-0.020 (-1.19%)
After-hours: Apr 2, 2026, 4:10 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $88.17 million as of April 2, 2026. Its market cap has increased by 96.81% in one year.
Market Cap
88.17M
Enterprise Value
84.13M
1-Year Change
96.81%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $88.17M, a decrease of -37.56%. That is a compound annual growth rate of -3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 88.17M | 13.24% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 92.99M |
| Vivani Medical | 91.42M |
| TuHURA Biosciences | 89.65M |
| Seres Therapeutics | 88.86M |
| Gossamer Bio | 86.84M |
| Anixa Biosciences | 85.50M |
| Kazia Therapeutics | 83.87M |
| PolyPid | 83.78M |